OpenAI and Anthropic Announce Comprehensive Crackdown on Secondary Market Trading: Unauthorized SPV Investments to be Nullified
According to Datum Beat monitoring, two AI giants with a combined valuation approaching $2 trillion are simultaneously cleaning up their cap tables on the eve of their IPOs.
OpenAI today published a formal policy on its website, announcing that all unauthorized equity transfers are deemed invalid, including direct transfers, SPV (Special Purpose Vehicle) shares, tokenized ownership, and forward contracts. Parties involved in these transfers will not receive any economic value and may also violate U.S. securities laws. As early as August 2025, OpenAI had publicly warned investors to beware of unauthorized SPV scams, and this move now formalizes the rules.
Anthropic has also tightened its policy. The company directly used the term "void" instead of "voidable" on its equity trading policy page. Cryptocurrency lawyer Gabriel Shapiro pointed out that this is the most aggressive legal stance under Delaware corporate law: a voidable transaction can be rescued, but a void transaction is legally considered to have "never occurred." Sellers can retain both the shares and the money received, while buyers can only seek recourse upstream. Anthropic specifically named several platforms, including Open Door Partners, Unicorns Exchange, Forge Global, and Hiive, announcing that shares purchased through these channels do not carry any shareholder rights.
This crackdown comes against the backdrop of a frenzied secondary market. In February of this year, Anthropic's primary financing valuation was $3.8 trillion, but the secondary market has surged to around $10 trillion. OpenAI is valued at $852 billion. Both companies plan to go public in the fourth quarter of this year, cleaning up their cap tables from uncontrolled "wild shareholders" before listing. This move is both a compliance requirement and a bid for pricing power.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment
According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
BUZZ-3M India shares fall to 19-month low due to quarterly profit decline
Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.
After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.
